Cancel
Biocogniv
See Linkedin
Biocogniv Employees
6 people indexed:
-
jjxw6wh23t@h693t5uw4.x00 Sign up to see email
-
1q49y@7083ez7q2.5lw Sign up to see email
-
9k583jh@f89hhuwl0.ps2 Sign up to see email
-
yda0a0xy@45u58xl12.2fu Sign up to see email
-
l87l55@9t4l3s6tp.s7p Sign up to see email
-
x65wt@3wsaz9qu9.h6t Sign up to see email
Biocogniv Company Information
Biocogniv, formerly known as Biocogniv Inc, is a healthcare company located in Burlington, VT, USA. With a team of six, Biocogniv operates within the healthcare industry, specifically focusing on AI diagnostics for acute care. The company is a part of the Y-Combinator S20 batch and serves regions across the United States and Canada. Biocogniv has received FDA Breakthrough Designation for its Sepsis aiMarker™, a tool that can detect and predict sepsis up to 72 hours in advance using routine laboratory panels collected in emergency rooms. This innovation is part of their broader effort to utilize state-of-the-art AI alongside routine tests to identify acute conditions before they become irreversible. Biocogniv’s proprietary platforms and datasets support real-world evidence on a large scale, with over 16 million patient encounters and 1 billion lab results processed. Their cloud-based platform, ClinOS™, connects to multiple hospital systems across the US, handling thousands of laboratory tests daily. The company’s pipeline of aiMarkers™ includes diagnostic and predictive tools for various conditions, including acute kidney injury and GI bleed. Biocogniv collaborates with several key partners such as UTMB Health, St. Joseph’s General Hospital, Vituity, NIH, and NSF.
Report inaccurate information
Report inaccurate information